Status:
COMPLETED
Biofeedback Training, Efficacy Evaluation of Fibromyalgia Treatment, a Pilot Study
Lead Sponsor:
University of Cagliari
Conditions:
Biofeedback, Psychology
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Biofeedback equipment is classified by the Food and Drug Administration (FDA) as medical device class II and this type of equipment/treatment has shown evidence regarding stress management. In fibrom...
Detailed Description
Background and rationale of study Fibromyalgia (FM) is a chronic disease, it is characterised by persistent and diffused musculoskeletal pain with not well defined etiology. Fibromyalgia often occurs...
Eligibility Criteria
Inclusion
- All patients diagnosed with fibromyalgia afferent to the clinic of pain therapy of San Giovanni hospital in Cagliari, Sardegna. Psychiatric comorbidities have no exclusion criterion
Exclusion
- \- Patients with cognitive difficulties and/or diagnoses of mental retardation and male patients will not be included in the study. Male patients will be excluded because the diagnosy of FM is infrequent in male patients and it was decided not to have bias because of the low amount of patients included in the study
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04121832
Start Date
September 1 2019
End Date
December 23 2022
Last Update
March 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
P.O. San Giovanni di Dio, AOU Cagliari
Cagliari, Italy, 09100